Skip to Main Content

  • For this Chapter in the Goodman & Gillman Workbook and Study Guide go to Chapter 46: Targeted Anticancer Therapies

    • Provides a real life scenario in a Clinical Case-format, based on the specific chapter content

    • Includes Clinical Cases, Key Concepts, Summary Quizzes and Drugs Listed in the Chapter

    • Visit the Study Guide/Casebook to see if you have mastered the chapter content!

INTRODUCTION

A Note on Treatment Regimens

Cancer treatment regimens change to reflect continuous advances in basic and clinical science: new drugs, both small molecules and biologicals; improved methods of targeting and timing of drug delivery; agents with altered pharmacokinetic properties and selectivities; the use of rational multidrug combinations; and greater knowledge of the basic cell biology of tumorigenesis, metastasis, and immune function, amongst other advances. As a consequence, this chapter presents relatively few detailed treatment regimens; rather, we refer the reader to the web-based resources of the U.S. FDA and the NCCN. Table 67–1 provides two examples of therapeutic regimens that illustrate the complexity of current cancer drug therapy.

Table 67–1Cancer Treatment Regimens: Complexities and Resources

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.